Genicular Artery Embolization for the Treatment of Knee Osteoarthritis

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 10, 2019

Primary Completion Date

October 29, 2021

Study Completion Date

October 29, 2021

Conditions
Knee OsteoarthritisDegenerative Joint Disease of Knee
Interventions
DEVICE

Embozene MicroSpheres

Embozene is a medical device made by Boston Scientific approved in the United States for the treatment of hypervascular tumors and arteriovenous malformations. It consists of thousands of microscopic spheres that are injected into the artery in the knee going to the region of pain. One of the causes of pain in the setting of knee arthritis is increased blood flow going to the specific area of pain. The goal of this procedure is to decrease the blood flow (embolize) to the specific region of the knee that is causing your pain. This is done by infusing Embozene particles into the specific blood vessel (genicular artery) supplying the area of pain in the knee.

Trial Locations (1)

90404

Siddharth Padia, M.D., Santa Monica

Sponsors
All Listed Sponsors
collaborator

Boston Scientific Corporation

INDUSTRY

lead

Siddharth Padia, MD

OTHER

NCT03491397 - Genicular Artery Embolization for the Treatment of Knee Osteoarthritis | Biotech Hunter | Biotech Hunter